Rebalix
Logo SPDRSPDR · sheet of 10 September 2026
ETF sheet · official issuer and register data

State Street® Global Dividend Spotlight Active Equity UCITS ETF (Acc)

GDSF · IE000KBUL630 · USD · domicile Ireland
Equity · Global · DividendactiveSFDR art. 8
Comparison benchmark: MSCI World High Dividend Yield Index
TER
0.45%+ trans. 0.04%
Fund size
5 m EUR
Tracking difference
not computable
🇮🇹 tax rate
26.00%white list 0.00%
Replication
Gestione attiva (dal KID)active management
Income
Accumulating
Launch 8 Feb 2026 · costs from the KID as of 2 Sept 2026 · 40 securities held · 8 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 5 Aug 2026
Investment objective The objective of the Fund is to generate capital growth over the long term through investment in global equity securities. Investment policies The investment policy of the fund is to outperform the MSCI World High Dividend Yield Index (the "Index") by primarily investing in high dividend yielding global equities. The fund will seek to achieve the objective by using a proprietary active investment strategy. This strategy will apply a fundamentally driven and bottom-up research process to identify companies considered to be trading at…

Performance since series start (in euro) — base 100

9 Feb 20268 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
10895106
High 108 (3 Sept 2026) · low 95 (20 Mar 2026) · last 106. Past performance is not indicative of future results.

Returns in euro

1 yearseries too young
3 yearsseries too young
5 yearsseries too young
10 yearsseries too young
Since series start+6.1%

Risk · 1 / 3 / 5 years

Volatility (ann.)
Max drawdown
Sharpe
Sortino
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · GDSF · IE000KBUL6301
RebalixGDSF · IE000KBUL630 · sheet of 10 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years
Not honestly computable: active management: deviation from the index is management, not replication

Holdings

Portfolio as declared by the issuer · 31 Aug 2026 · 40 securities · top-10 weight = 32.7%
Top holdingsWeight
ConocoPhillips3.9%
Merck & Co. Inc.3.8%
Publicis Groupe SA3.6%
BNP Paribas S.A. Class A3.4%
Home Depot Inc.3.4%
M&T Bank Corporation3.1%
Cigna Group3.0%
Roche Holding Ltd3.0%
Sanofi SA2.9%
RPM International Inc.2.8%
Countries (% of fund)
United States44.9%France16.2%United Kingdom7.2%Switzerland5.3%Ireland3.0%
Sectors (% of fund)
Health Care26.8%Industrials13.1%Financials12.9%Consumer Staples12.3%Energy11.0%

Listing venues

ESMA register (FIRDS) and official exchange lists
GDSF · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
+ 4 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · www.ssga.com/library-content/kids?isin=IE000KBUL630&documentType=kid&c
Factsheet · www.ssga.com/library-content/products/factsheets/etfs/emea/factsheet-e
Prospectus · www.ssga.com/library-content/products/fund-docs/etfs/emea/1-IE-EN-FP-I
The live sheet, always up to date
rebalix.com/en/etf/IE000KBUL630
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · GDSF · IE000KBUL6302